POLYPOIDAL CHOROIDAL VASCULOPATHY
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye injection aims to save sight from rare, leaky blood vessels
Disease control Recruiting nowThis study is testing a medication called faricimab, given as an injection into the eye, to see if it can help control a rare eye disease called polypoidal choroidal vasculopathy (PCV). PCV causes abnormal, leaky blood vessels in the back of the eye that can lead to vision loss. …
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE4 • Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New personalized eye treatment could stretch injections to every 4 months
Disease control Recruiting nowThis study is testing a personalized, high-dose version of an existing eye injection (aflibercept 8mg) for people with a specific eye condition called polypoidal choroidal vasculopathy (PCV). The goal is to see if this stronger dose, given on a flexible schedule, can effectively …
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated Mar 02, 2026 15:25 UTC